OxySure Systems, a medical technology company that focuses on the design, manufacture and distribution of specialty respiratory and medical solutions, has developed a safe and easy-to-use solution to produce medically pure (USP) oxygen from inert powders.
The company owns numerous issued patents and patents pending on this technology, which is designed to make the provision of emergency oxygen safer, more accessible and easier to use than traditional oxygen provision systems.
OxySure’s efforts are guided by CEO Julian T. Ross, who is also the OxySure founder and technology developer (holds nine patents).
With more than 25 years of experience in technology, manufacturing and finance, Ross has managed development of production capabilities, partnerships and alliances; managed the development of sales, distribution and licensing partnerships; raised in excess of $14 million in debt and equity to fund operations; and took OxySure public in 2011 through an S-1 registration with the Securities and Exchange Commission.
Ross is backed by a highly experienced team of directors and an equally as knowledgeable advisory board. Collectively, the team has experience in healthcare, management, business development, mergers & acquisitions, operations, private practice medicine and more.
For more information, visit www.oxysure.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
